When combined with CTLA-4 inhibitors, the ratio of Treg/CTL within the tumor decreased significantly, and the release of inflammatory factors increased, which eventually caused the inhibition of distant tumor growth [36]. The gene discussed is CTLA4; the disease is neoplasm.